Email updates

Keep up to date with the latest news and content from BMC Ophthalmology and BioMed Central.

Download references

Open Access Highly Accessed

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

David Eveleth*, Carla Starita and Charles Tressler

BMC Ophthalmology 2012, 12:9  doi:10.1186/1471-2415-12-9

Include


Format